PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 10856895-0 2000 Diazepam-binding inhibitor/acyl-CoA-binding protein mRNA and peripheral benzodiazepine receptor mRNA in endocrine and immune tissues after prenatal diazepam exposure of male and female rats. Diazepam 148-156 diazepam binding inhibitor Rattus norvegicus 0-51 10856895-5 2000 Prenatal diazepam increased DBI/ACBP mRNA expression in male fetal adrenal and in fetal and PN14 testis. Diazepam 9-17 diazepam binding inhibitor Rattus norvegicus 28-31 10856895-5 2000 Prenatal diazepam increased DBI/ACBP mRNA expression in male fetal adrenal and in fetal and PN14 testis. Diazepam 9-17 diazepam binding inhibitor Rattus norvegicus 32-36 10856895-9 2000 The effects of prenatal diazepam were superimposed on treatment-independent sex differences in DBI/ACBP mRNA and PBR mRNA expression. Diazepam 24-32 diazepam binding inhibitor Rattus norvegicus 95-98 10856895-9 2000 The effects of prenatal diazepam were superimposed on treatment-independent sex differences in DBI/ACBP mRNA and PBR mRNA expression. Diazepam 24-32 diazepam binding inhibitor Rattus norvegicus 99-103 1597138-1 1992 Diazepam binding inhibitor-like immunoreactivity (DBI-LI) in normal and hypophysectomized (HPX) rat testis was studied by light and electron microscopic immunohistochemistry. Diazepam 0-8 diazepam binding inhibitor Rattus norvegicus 50-53 9576607-1 1998 Recently, an 86-amino acid polypeptide with high affinity for diazepam binding sites, termed diazepam-binding inhibitor (DBI), has been found in the rat brain. Diazepam 62-70 diazepam binding inhibitor Rattus norvegicus 93-119 9576607-1 1998 Recently, an 86-amino acid polypeptide with high affinity for diazepam binding sites, termed diazepam-binding inhibitor (DBI), has been found in the rat brain. Diazepam 62-70 diazepam binding inhibitor Rattus norvegicus 121-124 9022045-1 1997 The diazepam binding inhibitor [DBI, also known as acyl-CoA-binding protein, (ACBP), or endozepine] is a 10-kD protein that has been suggested to be involved in the regulation of several biological processes such as acyl-CoA metabolism, steroidogenesis, insulin secretion, and gamma-aminobutyric acid type A (GABA(A))/benzodiazepine receptor modulation. Diazepam 4-12 diazepam binding inhibitor Rattus norvegicus 32-35 9022045-1 1997 The diazepam binding inhibitor [DBI, also known as acyl-CoA-binding protein, (ACBP), or endozepine] is a 10-kD protein that has been suggested to be involved in the regulation of several biological processes such as acyl-CoA metabolism, steroidogenesis, insulin secretion, and gamma-aminobutyric acid type A (GABA(A))/benzodiazepine receptor modulation. Diazepam 4-12 diazepam binding inhibitor Rattus norvegicus 78-82 9022045-1 1997 The diazepam binding inhibitor [DBI, also known as acyl-CoA-binding protein, (ACBP), or endozepine] is a 10-kD protein that has been suggested to be involved in the regulation of several biological processes such as acyl-CoA metabolism, steroidogenesis, insulin secretion, and gamma-aminobutyric acid type A (GABA(A))/benzodiazepine receptor modulation. Diazepam 4-12 diazepam binding inhibitor Rattus norvegicus 88-98 7670003-2 1995 Recently, an 86-amino acid polypeptide with high affinity for diazepam binding sites, termed diazepam-binding inhibitor (DBI), has been found in the rat brain. Diazepam 62-70 diazepam binding inhibitor Rattus norvegicus 93-119 7670003-2 1995 Recently, an 86-amino acid polypeptide with high affinity for diazepam binding sites, termed diazepam-binding inhibitor (DBI), has been found in the rat brain. Diazepam 62-70 diazepam binding inhibitor Rattus norvegicus 121-124 8159805-1 1994 This report describes the purification and characterization from rat brain of DBI39-75, a novel, biologically active processing product of diazepam binding inhibitor (DBI). Diazepam 139-147 diazepam binding inhibitor Rattus norvegicus 78-81 8168866-0 1994 Diazepam binding inhibitor fragment 33-50 (octadecaneuropeptide) immunoreactivity in the cerebellar cortex is restricted to glial cells. Diazepam 0-8 diazepam binding inhibitor Rattus norvegicus 43-63 8232254-1 1993 Acyl-CoA-binding protein has been isolated independently by five different groups based on its ability to (1) displace diazepam from the GABAA receptor, (2) affect cell growth, (3) induce medium-chain acyl-CoA-ester synthesis, (4) stimulate steroid hormone synthesis, and (5) affect glucose-induced insulin secretion. Diazepam 119-127 diazepam binding inhibitor Rattus norvegicus 0-24 1664066-0 1991 Immunohistochemistry of diazepam binding inhibitor (DBI) in the central nervous system and peripheral organs: its possible role as an endogenous regulator of different types of benzodiazepine receptors. Diazepam 24-32 diazepam binding inhibitor Rattus norvegicus 52-55 1780035-1 1991 Diazepam binding inhibitor (DBI) is a peptide, initially identified for its ability of displacing the binding of diazepam. Diazepam 113-121 diazepam binding inhibitor Rattus norvegicus 0-26 1780035-1 1991 Diazepam binding inhibitor (DBI) is a peptide, initially identified for its ability of displacing the binding of diazepam. Diazepam 113-121 diazepam binding inhibitor Rattus norvegicus 28-31 1780035-6 1991 Moreover, the biosynthesis of DBI is up-regulated in the cerebellum and cerebral cortex of rats made tolerant to diazepam, suggesting that changes in the biosynthesis of DBI might be one of the mechanisms eliciting tolerance to benzodiazepine. Diazepam 113-121 diazepam binding inhibitor Rattus norvegicus 30-33 1780035-6 1991 Moreover, the biosynthesis of DBI is up-regulated in the cerebellum and cerebral cortex of rats made tolerant to diazepam, suggesting that changes in the biosynthesis of DBI might be one of the mechanisms eliciting tolerance to benzodiazepine. Diazepam 113-121 diazepam binding inhibitor Rattus norvegicus 170-173 1664066-1 1991 The distribution of diazepam binding inhibitor (DBI), a multi-function peptide which has recently been discovered, was studied in the rat and human central nervous system and in peripheral organs of the rat by light and electron microscopical immunohistochemistry. Diazepam 20-28 diazepam binding inhibitor Rattus norvegicus 48-51 3456171-0 1986 Study of an octadecaneuropeptide derived from diazepam binding inhibitor (DBI): biological activity and presence in rat brain. Diazepam 46-54 diazepam binding inhibitor Rattus norvegicus 74-77 3413133-1 1988 Diazepam binding inhibitor (DBI), an endogenous 10-kDa polypeptide was isolated from rat and human brain by monitoring displacement of radioactive diazepam bound to specific recognition sites in brain synaptic and mitochondrial membranes. Diazepam 147-155 diazepam binding inhibitor Rattus norvegicus 0-32 2821428-5 1987 Tolerance to diazepam increased the dynamic state of an octadecaneuropeptide (ODN), derived from DBI, in the cerebellum and cortex. Diazepam 13-21 diazepam binding inhibitor Rattus norvegicus 97-100 1649940-1 1991 Diazepam binding inhibitor (DBI) is a 9-kD polypeptide that was first isolated in 1983 from rat brain by monitoring its ability to displace diazepam from the benzodiazepine (BZD) recognition site located on the extracellular domain of the type A receptor for gamma-aminobutyric acid (GABAA receptor) and from the mitochondrial BZD receptor (MBR) located on the outer mitochondrial membrane. Diazepam 140-148 diazepam binding inhibitor Rattus norvegicus 0-26 1649940-1 1991 Diazepam binding inhibitor (DBI) is a 9-kD polypeptide that was first isolated in 1983 from rat brain by monitoring its ability to displace diazepam from the benzodiazepine (BZD) recognition site located on the extracellular domain of the type A receptor for gamma-aminobutyric acid (GABAA receptor) and from the mitochondrial BZD receptor (MBR) located on the outer mitochondrial membrane. Diazepam 140-148 diazepam binding inhibitor Rattus norvegicus 28-31 1646996-1 1991 Evidence suggests that endogenous benzodiazepine receptor ligands such as diazepam binding inhibitor (DBI) and its metabolite octadecaneuropeptide (ODN) may be implicated in the pathogenesis of hepatic encephalopathy. Diazepam 74-82 diazepam binding inhibitor Rattus norvegicus 126-146 1646996-1 1991 Evidence suggests that endogenous benzodiazepine receptor ligands such as diazepam binding inhibitor (DBI) and its metabolite octadecaneuropeptide (ODN) may be implicated in the pathogenesis of hepatic encephalopathy. Diazepam 74-82 diazepam binding inhibitor Rattus norvegicus 148-151 3029781-2 1987 We used a cDNA probe complementary to DBI mRNA and a specific antibody for rat DBI to study in rat brain how the dynamic state of DBI can be affected after protracted (three times a day for 10 days) treatment with diazepam and chlordiazepoxide by oral gavage. Diazepam 214-222 diazepam binding inhibitor Rattus norvegicus 38-41 3029781-2 1987 We used a cDNA probe complementary to DBI mRNA and a specific antibody for rat DBI to study in rat brain how the dynamic state of DBI can be affected after protracted (three times a day for 10 days) treatment with diazepam and chlordiazepoxide by oral gavage. Diazepam 214-222 diazepam binding inhibitor Rattus norvegicus 79-82 3029781-2 1987 We used a cDNA probe complementary to DBI mRNA and a specific antibody for rat DBI to study in rat brain how the dynamic state of DBI can be affected after protracted (three times a day for 10 days) treatment with diazepam and chlordiazepoxide by oral gavage. Diazepam 214-222 diazepam binding inhibitor Rattus norvegicus 79-82 3456171-1 1986 An endogenous brain neuropeptide with 104 amino acid residues that modulates gamma-aminobutyric acid receptor function was termed DBI because it displaces diazepam from its specific brain binding sites. Diazepam 155-163 diazepam binding inhibitor Rattus norvegicus 130-133 32272540-0 2011 Diazepam Enhances Production of Diazepam-Binding Inhibitor (DBI), a Negative Saliva Secretion Regulator, Localized in Rat Salivary Gland. Diazepam 0-8 diazepam binding inhibitor Rattus norvegicus 32-58 21282931-0 2011 Diazepam enhances production of diazepam-binding inhibitor (DBI), a negative saliva secretion regulator, localized in rat salivary gland. Diazepam 0-8 diazepam binding inhibitor Rattus norvegicus 32-58 21282931-0 2011 Diazepam enhances production of diazepam-binding inhibitor (DBI), a negative saliva secretion regulator, localized in rat salivary gland. Diazepam 0-8 diazepam binding inhibitor Rattus norvegicus 60-63 21282931-3 2011 In this study, we investigated the effect of repetitive administration of diazepam (DZP) on salivary secretion and expression of DBI mRNA and peptide. Diazepam 74-82 diazepam binding inhibitor Rattus norvegicus 129-132 21282931-3 2011 In this study, we investigated the effect of repetitive administration of diazepam (DZP) on salivary secretion and expression of DBI mRNA and peptide. Diazepam 84-87 diazepam binding inhibitor Rattus norvegicus 129-132 21282931-5 2011 Repetitive administration, but not single administration, of 0.4 mg/kg DZP caused inhibition of salivary secretion and enhanced expression of DBI, PACAP, and PBR mRNA in rat salivary gland, with an increase in production of DBI peptide. Diazepam 71-74 diazepam binding inhibitor Rattus norvegicus 142-145 21282931-5 2011 Repetitive administration, but not single administration, of 0.4 mg/kg DZP caused inhibition of salivary secretion and enhanced expression of DBI, PACAP, and PBR mRNA in rat salivary gland, with an increase in production of DBI peptide. Diazepam 71-74 diazepam binding inhibitor Rattus norvegicus 224-227 21282931-6 2011 These results suggest that repetitive administration of DZP stimulates DBI production, which may result in an increase in the suppressive effect of DZP on salivary secretion. Diazepam 56-59 diazepam binding inhibitor Rattus norvegicus 71-74 21282931-6 2011 These results suggest that repetitive administration of DZP stimulates DBI production, which may result in an increase in the suppressive effect of DZP on salivary secretion. Diazepam 148-151 diazepam binding inhibitor Rattus norvegicus 71-74 32272540-0 2011 Diazepam Enhances Production of Diazepam-Binding Inhibitor (DBI), a Negative Saliva Secretion Regulator, Localized in Rat Salivary Gland. Diazepam 0-8 diazepam binding inhibitor Rattus norvegicus 60-63 32272540-3 2011 In this study, we investigated the effect of repetitive administration of diazepam (DZP) on salivary secretion and expression of DBI mRNA and peptide. Diazepam 74-82 diazepam binding inhibitor Rattus norvegicus 129-132 32272540-3 2011 In this study, we investigated the effect of repetitive administration of diazepam (DZP) on salivary secretion and expression of DBI mRNA and peptide. Diazepam 84-87 diazepam binding inhibitor Rattus norvegicus 129-132 32272540-5 2011 Repetitive administration, but not single administration, of 0.4 mg/kg DZP caused inhibition of salivary secretion and enhanced expression of DBI, PACAP, and PBR mRNA in rat salivary gland, with an increase in production of DBI peptide. Diazepam 71-74 diazepam binding inhibitor Rattus norvegicus 142-145 32272540-5 2011 Repetitive administration, but not single administration, of 0.4 mg/kg DZP caused inhibition of salivary secretion and enhanced expression of DBI, PACAP, and PBR mRNA in rat salivary gland, with an increase in production of DBI peptide. Diazepam 71-74 diazepam binding inhibitor Rattus norvegicus 224-227 32272540-6 2011 These results suggest that repetitive administration of DZP stimulates DBI production, which may result in an increase in the suppressive effect of DZP on salivary secretion. Diazepam 56-59 diazepam binding inhibitor Rattus norvegicus 71-74 32272540-6 2011 These results suggest that repetitive administration of DZP stimulates DBI production, which may result in an increase in the suppressive effect of DZP on salivary secretion. Diazepam 148-151 diazepam binding inhibitor Rattus norvegicus 71-74